Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

SWHFX vs ETHSX overlap: 69% of top holdings shared

Bottom line

How much do SWHFX and ETHSX overlap?

69% of their top holdings overlap by weight. 16 securities appear in both funds' top 25, making up 60.2% of SWHFX's assets and 67.6% of ETHSX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

SWHFXETHSX
Weight overlap (top 25)69%
Shared holdings16
Weight in shared holdings60.2%67.6%
Total positions8042
Expense ratio0.8%1.18%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings SWHFX and ETHSX have in common

Holding% of SWHFX% of ETHSXOverlap
Eli Lilly & Co13.92%12.47%12.47%
Johnson & Johnson6.94%6.45%6.45%
AbbVie Inc5.81%6.46%5.81%
Merck & Co Inc4.98%5.08%4.98%
UnitedHealth Group Inc4.74%5.49%4.74%
Gilead Sciences Inc3.24%3.34%3.24%
Novartis AG2.92%1.65%1.65%
Bristol-Myers Squibb Co2.44%4.25%2.44%
Medtronic PLC2.29%1.80%1.80%
Roche Holding AG2.29%5.44%2.29%
Thermo Fisher Scientific Inc2.16%2.79%2.16%
Stryker Corp2.11%2.21%2.11%
Vertex Pharmaceuticals Inc1.89%3.38%1.89%
Boston Scientific Corp1.60%2.18%1.60%
Abbott Laboratories1.60%1.65%1.60%
Sanofi SA1.31%2.95%1.31%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in SWHFX

  1. Amgen Inc — 2.58%
  2. Gsk Plc — 1.73%
  3. Cigna Group/The — 1.51%
  4. Danaher Corp — 1.47%
  5. Elevance Health Inc — 1.45%
  6. Incyte Corp — 1.37%
  7. Ipsen SA — 1.34%
  8. Becton Dickinson & Co — 1.24%
  9. Astellas Pharma Inc — 1.19%

Only in ETHSX

  1. AstraZeneca PLC — 6.24%
  2. Intuitive Surgical Inc — 2.72%
  3. Lonza Group AG — 1.77%
  4. Novo Nordisk A/S — 1.71%
  5. Argenx SE — 1.61%
  6. Royalty Pharma PLC — 1.58%
  7. Neurocrine Biosciences Inc — 1.41%
  8. Mettler-Toledo International Inc — 1.36%
  9. Straumann Holding AG — 1.34%

Asset mix

Asset typeSWHFXETHSX
Stocks99.0%99.4%
Cash & short-term funds—0.3%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountrySWHFXETHSX
US78.6%69.4%
CH5.2%10.2%
GB3.4%7.8%
IE4.5%1.8%
FR2.6%3.2%
DK0.7%2.9%
JP2.3%—
NL0.7%2.0%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do SWHFX and ETHSX overlap?
About 69% by weight. 16 securities appear in both funds' top 25 holdings; they make up 60.2% of SWHFX's assets and 67.6% of ETHSX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do SWHFX and ETHSX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, AbbVie Inc, Merck & Co Inc, UnitedHealth Group Inc.
Should I own both SWHFX and ETHSX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, SWHFX or ETHSX?
SWHFX is broader, with 80 positions versus 42 for ETHSX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.